Feasibility: A Costly Bottleneck

Before Biogenesis, Innovo relied on a manual and operationally inefficient feasibility system that was consuming over 20 hours per week. With a volume of up to a dozen questionnaires coming in per week, their team was burdened with repetitive entry, scattered documents, and excessive back-and-forth emailing. Key information such as patient enrollment, population data, PI experience, and equipment specifics were stored in multiple locations, consuming extra time.

Success for Innovo meant reducing time spent on feasibility from hours to just minutes, having a centralized source of truth for their data, and capitalizing on missed opportunities so they can dedicate more time to their patients. They aimed to complete more feasibility per week, increase their win rate, and offer sponsors a more realistic picture of their site capabilities. Without change, the inefficiencies in their current system would limit their growth opportunity, and risk losing more studies to competitors.

Key challenges included:

• Missed opportunities: slow turnaround times and inconsistent feasibility cost the site network valuable study awards.
• Data management: Data was not consolidated or centralized, instead capabilities were stored in multiple locations and were difficult to cross-reference.
• Operational inefficiencies: excessive back-and-forth communication and scattered data stole valuable time away from winning opportunities.

With these obstacles in the way, Innovo needed strategic innovation that could turn their feasibility from an obstacle to a competitive advantage.

Innovo Leverages Biogenesis to Transform Feasibility

Innovo deploys Biogenesis' platform to modernize feasibility to expand and dominate their study pipeline.

By partnering with Biogenesis, Innovo is able to:

• Harness intelligent, winning answers: Innovo now synthesizes their site data and previous answers to create competitive answers powered by Biogenesis' AI.
• Leverage insight-driven PI recommendations: identify the best investigators for each trial, based on past experience and therapeutic expertise to improve their chances at winning each trial.
• Automate repetitive work: using a repository of site data, questions are auto-filled to turn hours of work into just minutes.
• Centralize data: site capabilities, PI experience, equipment, and all other details are consolidated into a centralized database for easy extraction, tracking, and updating.

By integrating Biogenesis, Innovo redefined their feasibility as a driver of growth, and has their sights set on awarded studies.

Innovo Achieves Record Study Wins

Innovo recorded significant results that revamped their business:

• 65% more studies won quarter over quarter
• 90% time savings on feasibility
• 70% study win rate overall

With Biogenesis, Innovo not only streamlined a time-consuming obstacle, but also unlocked the ability to pursue more opportunities, respond sooner, and secure more studies than ever before.

Innovo Continues to Drive Network Growth with Biogenesis

Innovo continues to capitalize on their competitive advantage to strengthen sponsor relationships and open the door to new opportunities. Time that was previously spent on sifting through documents, emailing back-and-forth with PIs, and cross-referencing data across multiple sources of truth, is now spent on targeting new opportunities, and growing their rapidly expanding network to deliver treatments to more patients, at scale. With Biogenesis powering their feasibility process, Innovo has positioned itself as a leading site network that is agile, precise, and delivers promising value to both sponsors and their patients.